A Mavroidi
Overview
Explore the profile of A Mavroidi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Katsiari M, Mavroidi A, Platsouka E, Nikolaou C
J Glob Antimicrob Resist
. 2018 Feb;
14:51-57.
PMID: 29471109
Objectives: This study aimed to determine potential host-, pathogen-, infection- and treatment-related risk factors that might predict a fulminant fatal course of bacteraemia caused by extensively drug-resistant Acinetobacter baumannii (XDR-Aba)....
2.
Mavroidi A, Neonakis I, Liakopoulos A, Papaioannou A, Ntala M, Tryposkiadis F, et al.
Euro Surveill
. 2011 Oct;
16(41).
PMID: 22008199
This report describes the detection of Citrobacter koseri carrying K. pneumoniae carbapenemase (KPC-2) isolated in July 2011 from a Greek patient, who was also colonised by a Klebsiella pneumoniae strain...
3.
Mavroidi A, Paraskakis I, Pangalis A, Kirikou E, Charisiadou A, Athanasiou T, et al.
Clin Microbiol Infect
. 2007 Oct;
13(12):1213-6.
PMID: 17944968
Serotype 19F pneumococci were a leading cause of infections among children in Athens, Greece during 2001-2006. In total, 143 19F isolates were typed by pulsed-field gel electrophoresis (PFGE), and 38...
4.
Mavroidi A, Tzelepi E, Miriagou V, Gianneli D, Legakis N, Tzouvelekis L
Microb Drug Resist
. 2002 May;
8(1):35-7.
PMID: 12002647
An Escherichia coli clinical strain resistant to all beta-lactams except carbapenems was isolated in a Greek hospital. Analysis of beta-lactamase content by isoelectric focusing, PCR assays specific for various bla...
5.
Mavroidi A, Tzelepi E, Tsakris A, Miriagou V, Sofianou D, Tzouvelekis L
J Antimicrob Chemother
. 2001 Oct;
48(5):627-30.
PMID: 11679551
An extended-spectrum beta-lactamase, IBC-2, produced by a clinical strain of Pseudomonas aeruginosa, was characterized. bla(IBC-2) was found, as a gene cassette, to be the sole gene within the variable region...
6.
Mavroidi A, Tzouvelekis L, Kyriakis K, Avgerinou H, Daniilidou M, Tzelepi E
Antimicrob Agents Chemother
. 2001 Aug;
45(9):2651-4.
PMID: 11502546
Eighty-seven out of 575 gonococci isolated in Greece from 1991 to 1998 belonged to serovar Bropyst and exhibited resistance to penicillin, tetracycline, erythromycin, and chloramphenicol. Conventional and molecular typing showed...
7.
Mavroidi A, Tsakris A, Tzelepi E, Pournaras S, Loukova V, Tzouvelekis L
J Antimicrob Chemother
. 2000 Dec;
46(6):1041-2.
PMID: 11102432
No abstract available.
8.
Tzelepi E, Arvanitidou M, Tzouvelekis L, Mavroidi A, Tsakris A
J Antimicrob Chemother
. 2000 Sep;
46(3):513-5.
PMID: 10980185
No abstract available.
9.
Mavroidi A, Tzouvelekis L, Tassios P, Flemetakis A, Daniilidou M, Tzelepi E
J Clin Microbiol
. 2000 Sep;
38(9):3489-91.
PMID: 10970412
Of the 331 Neisseria gonorrhoeae strains isolated in Greece from 1996 to 1999, 39 (11.8%) exhibited decreased susceptibility to quinolones due to gyrA and parC mutations. Conventional typing and pulsed-field...
10.
Tzelepi E, Kouppari G, Mavroidi A, Zaphiropoulou A, Tzouvelekis L
J Antimicrob Chemother
. 1999 Jun;
43(5):745-6.
PMID: 10382903
No abstract available.